Publication: 2293

Publication: 2293

Bendamustine and rituximab and lenalidomide (BRR) in the treatment of relapsed and refractory low grade non-Hodgkin lymphoma (NHL): Final results of phase 1 study NCCTG N1088/Alliance

URL

URL

Google Scholar

Citation:: J Clin Oncol vol 33 (suppl) abstr 8540

Meeting Instance:: ASCO 2015
Year:: 2015
Type:: Abstract
Sub type:: Poster General
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: pub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No

Parents:: None
Children:: 3596

Program:: OGC
Primary Committee:: Lymphoma
Sec. Committees:

Pharmas:
Grants:

Corr. Author:
Authors:: Grzegorz S. Nowakowski Betsy LaPlant William R. Macon Morie A. Gertz Thomas M. Habermann David J. Inwards Ivana N. Micallef Donald B. Wender John P. Leonard Thomas E. Witzig

Networks:: LAPS-MN026, NY018, SANFORD

Study: NCCTG-N1088
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 1

Keywords: